Free Trial
NASDAQ:FENC

Fennec Pharmaceuticals Q1 2025 Earnings Report

Fennec Pharmaceuticals logo
$6.30 +0.19 (+3.11%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$6.54 +0.24 (+3.79%)
As of 05/2/2025 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fennec Pharmaceuticals EPS Results

Actual EPS
N/A
Consensus EPS
-$0.12
Beat/Miss
N/A
One Year Ago EPS
N/A

Fennec Pharmaceuticals Revenue Results

Actual Revenue
N/A
Expected Revenue
$8.18 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fennec Pharmaceuticals Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Monday, May 12, 2025
Conference Call Time
12:30PM ET

Conference Call Resources

Fennec Pharmaceuticals Earnings Headlines

Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Fennec Pharmaceuticals Shares Down After 4Q Results
See More Fennec Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fennec Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your email.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals (NASDAQ:FENC)., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

View Fennec Pharmaceuticals Profile

More Earnings Resources from MarketBeat